Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by Gonzoruleon Apr 26, 2020 2:27pm
74 Views
Post# 30955113

RE:RE:From last MD@A financial report

RE:RE:From last MD@A financial report"Much less than the selling price..." is another way of saying "cheaper", and I've never been a fan of 'discounting' your product. It changes your brand trajectory and stigmatizes the quality. I wasn't thrilled with my last purchase of some of their sativa last week. The package date was early January and the contents were "dry". There was also a harshness that I equate with late or over ferting. It was a less than satisfying experience compared to previous purchases earlier in the year. Considering all the commentary here about how product is flying off the shelf - my expectations were maybe too ambitious. Oh well, maybe next time....

I agree with you though Walt that the future is bright, but I wish there was more info regarding sales of individual skus...how much of sales were from flower, how much from drinks - what are the margins, etc. Etc. Etc.


Bullboard Posts